StratifiCare Inc. is pleased to welcome industry veteran Edward (Ted) Ruppel to our Board of Advisors.
Ted Ruppel, President and CEO of Shape Memory Medical Inc., brings more than 25 years of entrepreneurial and medical device company management experience, including the IPO of Micrus Endovascular Corp. Ted was formerly EVP/CFO of Vascular Dynamics and Senior VP of R&D and Operations at Micrus Endovascular Corporation (acquired by J&J). He held previous management/operations roles at CBYON Inc., Biometric Imaging (acquired by BD), Applied Biosystems, and Spectra-Physics. Ted has a BSME from the University of Rochester and MBA (TRIUM - Jointly conferred by London School of Economics and Political Science, NYU Stern School of Business, and HEC Paris).
"Ted's extensive, proven background in management, operations and commercialization at numerous medical device and diagnostic companies is instrumental in providing realistic, timely feedbacks while we accelerate StratifiDen - the world's first Dengue prognostic test, and our subsequent pipeline products to market," said CEO Anthony Chua. "We look forward to the opportunity to work closely with Ted."